Compare Nuwellis Inc (NUWE) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Zillow Group Inc Class C — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while Zillow Group Inc Class C trades at $29.33 (market cap $6.59B). The key difference: Zillow Group Inc Class C is far larger — about 2995.5× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 9,134,294). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Zillow Group Inc Class C for 39 Days on average.
| NUWE | Z | |
|---|---|---|
Market Cap | $2.20M | $6.59B |
Volume | 121,544 | 9,134,294 |
Sector | Health | Media |
52-Week High | $146.65 | $78.04 |
52-Week Low | $0.68 | $27.13 |
Typical Hold Time | 26 Days | 39 Days |
Enterprise Value | -$1.52M | $6.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Zillow Group (Z) trades at $27.28, down 1.52% on the day, with technical indicators signaling a bearish trend amid weak moving averages. The company reported revenue of $2.58 billion in 2025, with net income turning positive at $23 million, and recent quarters show mixed earnings performance with two beats and one miss. Analyst sentiment is divided, with a consensus price target of $60.33, while news highlights focus on market competition and AI integration in real estate.
The stock faces headwinds from a challenging housing market and high valuation multiples, but long-term growth potential exists through its transaction platform expansion and AI initiatives. Risks include interest rate sensitivity and competitive pressures, yet institutional analyst coverage remains largely neutral to positive, suggesting cautious optimism for recovery if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
